Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Transdermal Drug Delivery Systems

Transdermal Drug Delivery Systems

Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...

Ophthalmic Drug Delivery Systems

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...

Drug Delivery Systems: Different Types

Drug Delivery Systems: Different Types

Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...

Modified-Release Drug Delivery Systems: Classification

Modified-Release Drug Delivery Systems: Classification

Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...

Modified-Release Drug Delivery Systems: Site-Targeted

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Recommending Sunscreen Products.

Skinmed·2025

Same author

Radiative trigger thresholds of foliar photoprotective pigment regulation for global vegetation.

Innovation (Cambridge (Mass.))·2024

Same author

The Arctic Plant Aboveground Biomass Synthesis Dataset.

Scientific data·2024

Same author

A Second Look at Niacin.

Skinmed·2023

Same author

Soil and plant-based ecosystem functions dataset of three land-use types in northwestern Virginia.

Data in brief·2023

Same author

Attack on Sunscreens Continues.

Skinmed·2021

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Published on: November 24, 2021

Cosmeceutical vehicles.

Howard Epstein¹

¹EMD Chemicals, Inc. (an affiliate of Merck KGaA, Darmstadt, Germany), Gibbstown, NJ 08027, USA. hepsteinskincare@yahoo.com

Clinics in Dermatology

|August 22, 2009

Summary

This summary is machine-generated.

Consumers expect premium performance and elegant aesthetics from high-cost skincare and haircare. For success, these high-performance products must deliver on claims to ensure consumer repurchase in a competitive market.

More Related Videos

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Characterization of Intra-Cartilage Transport Properties of Cationic Peptide Carriers

Characterization of Intra-Cartilage Transport Properties of Cationic Peptide Carriers

Published on: August 10, 2020

Related Experiment Videos

Last Updated: Jun 20, 2026

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Published on: November 24, 2021

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Encapsulation of Cancer Therapeutic Agent Dacarbazine Using Nanostructured Lipid Carrier

Published on: April 26, 2016

Characterization of Intra-Cartilage Transport Properties of Cationic Peptide Carriers

Characterization of Intra-Cartilage Transport Properties of Cationic Peptide Carriers

Published on: August 10, 2020

Area of Science:

Cosmetic Science
Dermatology
Consumer Product Development

Background:

The premium beauty market demands high-performance skincare and haircare products.
Consumers expect efficacy and superior aesthetic qualities justifying higher price points.
Repurchase intent is contingent upon products meeting performance claims.

Purpose of the Study:

To analyze the critical factors for success in the high-end skincare and haircare market.
To understand consumer expectations regarding performance and aesthetics in premium products.
To identify formulation strategies for non-irritating and elegant product vehicles.

Main Methods:

Market analysis of premium cosmetic products.
Consumer expectation surveys for skincare and haircare.
Formulation review of high-performance cosmetic vehicles.

Main Results:

Efficacy and demonstrable performance are paramount for consumer satisfaction and loyalty.
Aesthetic attributes, including texture and non-irritating properties, significantly influence consumer perception.
Successful products integrate high performance with elegant, consumer-friendly formulations.

Conclusions:

Product formulation must balance potent active ingredients with non-irritating, aesthetically pleasing vehicles.
Meeting both performance claims and sensory expectations is crucial for sustained success in the premium beauty sector.
Continuous innovation in formulation science is key to addressing evolving consumer demands in high-end cosmetics.